在CD4T细胞中的ProS1-MerTK信号传递:对TIL扩展和功能的影响
Annina Kurzay1, Sara Fresnillo Saló1, Anne Rahbech1
1National Center for Cancer Immune Therapy, Department of Oncology, University Hospital Herlev, Herlev, Denmark.
ProS1-MerTK信号增强CD4 T细胞功能和记忆形成,对于改善癌症采用细胞疗法 (ACT) 至关重要. 这一途径具有促进基于T细胞的癌症治疗的治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 细胞疗法细胞疗法
背景情况:
- 采用细胞疗法 (ACT) 主要侧重于CD8 T细胞,但CD4 T细胞因其关键作用越来越被认可.
- 默特基受体 (MerTK) 影响免疫反应和CD8 T细胞共刺激,但其在CD4 T细胞中的功能在很大程度上是未知的.
- 了解CD4 T细胞调节对于推进癌症免疫治疗策略至关重要.
研究的目的:
- 研究ProS1-MerTK信号传递在CD4T细胞功能中的作用和治疗潜力.
- 阐明ProS1-MerTK对CD4T细胞记忆,新陈代谢和极化的影响.
- 评估ProS1在增强瘤透淋巴细胞 (TILs) 的实用性.
主要方法:
- 在激活的CD4T细胞中分析ProS1-MerTK信号传递.
- 使用CRISPR-Cas9基因编辑来评估MerTK的功能.
- 瘤透性淋巴细胞 (TILs) 的体外扩张使用ProS1进行ACT.
主要成果:
- 在激活的CD4T细胞中,ProS1-MerTK信号被上调,促进记忆形成,代谢健康和增殖.
- 缺乏MerTK会影响CD4 T细胞的适应性,功能和1型免疫反应的两极分化.
- 在TIL扩张期间添加ProS1增强了CD4T细胞干细胞,记忆表型和辅助功能,同时减少了疲劳.
结论:
- ProS1-MerTK信号传递是调节CD4 T细胞功能和1型免疫反应的关键途径.
- 准ProS1-MerTK信号传递可以增强对ACT有利的CD4T细胞特性.
- 这一途径提出了一个有前途的治疗策略,以改善基于TIL的ACT治疗晚期黑色素瘤的结果.
更多相关视频
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
09:43Co-Culture and Transduction of Murine Thymocytes on Delta-Like 4-Expressing Stromal Cells to Study Oncogenes in T-Cell Leukemia
Published on: June 9, 2023
相关概念视频
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
